104 related articles for article (PubMed ID: 1952069)
1. Adaptation of the plasma renin radioimmunoassay for use with HIV-1 protease.
Hyland LJ; Meek TD
Anal Biochem; 1991 Aug; 197(1):225-30. PubMed ID: 1952069
[TBL] [Abstract][Full Text] [Related]
2. Could angiotensin I be produced from a renin substrate by the HIV-1 protease?
Sharma SK; Evans DB; Hui JO; Heinrikson RL
Anal Biochem; 1991 Nov; 198(2):363-7. PubMed ID: 1799223
[TBL] [Abstract][Full Text] [Related]
3. Development of activity assays for high-volume evaluation of human immunodeficiency virus (HIV) protease inhibitors in rat serum: results with ditekiren.
Wilkinson KF; Rush BD; Sharma SK; Evans DB; Ruwart MJ; Friis JM; Bohanon MJ; Tomich PK
Pharm Res; 1993 Apr; 10(4):562-6. PubMed ID: 8483839
[TBL] [Abstract][Full Text] [Related]
4. An ultrasensitive human immunodeficiency virus type 1 protease radioimmuno rate assay with a potential for monitoring blood levels of protease inhibitors in acquired immunodeficiency disease syndrome patients.
Evans DB; Vosters AF; McQuade TJ; Sharma SK
Anal Biochem; 1992 Nov; 206(2):288-92. PubMed ID: 1443599
[TBL] [Abstract][Full Text] [Related]
5. Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.
Poe M; Wu JK; Lin TY; Hoogsteen K; Bull HG; Slater EE
Anal Biochem; 1984 Aug; 140(2):459-67. PubMed ID: 6385771
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchange.
Hyland LJ; Tomaszek TA; Roberts GD; Carr SA; Magaard VW; Bryan HL; Fakhoury SA; Moore ML; Minnich MD; Culp JS
Biochemistry; 1991 Aug; 30(34):8441-53. PubMed ID: 1883830
[TBL] [Abstract][Full Text] [Related]
7. Expression and characterization of chimeric rDNA proteins engineered for purification and enzymatic cleavage.
Evans DB; Tarpley WG; Sharma SK
Protein Expr Purif; 1991; 2(2-3):205-13. PubMed ID: 1726560
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of the reaction of renin with nine synthetic peptide substrates.
Skeggs LT; Lentz KE; Kahn JR; Hochstrasser H
J Exp Med; 1968 Jul; 128(1):13-34. PubMed ID: 5662012
[TBL] [Abstract][Full Text] [Related]
9. On the specificity of human renin. Studies with peptide inhibitors.
Poulsen K; Haber E; Burton J
Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126
[TBL] [Abstract][Full Text] [Related]
10. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
[TBL] [Abstract][Full Text] [Related]
11. Primary and tertiary structure of the principal human adenylate kinase.
Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
[TBL] [Abstract][Full Text] [Related]
12. A rational approach in the search for potent inhibitors against HIV proteinase.
Hui KY; Manetta JV; Gygi T; Bowdon BJ; Keith KA; Shannon WM; Lai MH
FASEB J; 1991 Aug; 5(11):2606-10. PubMed ID: 1868985
[TBL] [Abstract][Full Text] [Related]
13. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
[TBL] [Abstract][Full Text] [Related]
14. Conformations of synthetic tetradecapeptide renin substrate and of angiotensin I in aqueous solution.
Oliveira MC; Juliano L; Paiva AC
Biochemistry; 1977 Jun; 16(12):2606-11. PubMed ID: 19034
[TBL] [Abstract][Full Text] [Related]
15. A solid phase assay for the protease of human immunodeficiency virus.
Wondrak EM; Copeland TD; Louis JM; Oroszlan S
Anal Biochem; 1990 Jul; 188(1):82-5. PubMed ID: 2221372
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
Wang W; Liang TC
Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of recombinant human renal renin: effect of histidine in the P2 subsite on pH dependence.
Green DW; Aykent S; Gierse JK; Zupec ME
Biochemistry; 1990 Mar; 29(12):3126-33. PubMed ID: 2186807
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of potent, low molecular weight renin inhibitors.
Sueiras-Diaz J; Jones DM; Szelke M; Deinum J; Svensson L; Westerlund C; Sohtell M
J Pept Res; 1997 Oct; 50(4):248-61. PubMed ID: 9352463
[TBL] [Abstract][Full Text] [Related]
20. Crystallographic studies of reduced bond inhibitors complexed with an aspartic proteinase.
Foundling SI; Cooper J; Watson FE; Pearl LH; Hemmings A; Wood SP; Blundell T; Hallett A; Jones DM; Sueiras J
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S59-68. PubMed ID: 2485065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
